Siemens CLINITEST Rapid Antigen Self Test - 20 Test/Box
As societies try to overcome the COVID-19 epidemic, preventing the spread of the virus with a quick and easy test that is accessible to everyone emerges as a critical need for public health. To address this need, Siemens Healthineers offers an easy-to-use antigen test for the detection of the SARS-CoV-2 virus that causes COVID-19. The bedside cassette test CLINITEST Rapid COVID-19 Antigen Test1 does not require laboratory tools or specialists for administration and provides results within 15 minutes. Developed and tested by a Siemens Healthineers solution partner, this CE-certified test shows 96.72% sensitivity and 99.2% specificity, according to a clinical study on 317 subjects. This research was carried out with the participation of operators of different competencies at six different locations, including a hospital, a health center, a university campus and an oncology unit. Siemens Healthineers aims to meet such testing needs as the pandemic continues to spread. However, the test is awaiting completion of FDA review for Emergency Use Authorization. Head of Bedside Diagnostics at Siemens Healthineers PhD. Christoph Pedain states: “There is a great need for reliable tests that can quickly identify individuals with the virus and help minimize the spread of COVID-19, especially in areas where people gather and traffic is high. As quality is at the forefront of test reliability criteria for decision makers, it was extremely important that the clinical investigation for this test be able to evaluate the variable clinical conditions that can be expected when performing a rapid antigen test. “This rapid antigen test makes SARS-CoV-2 testing accessible to a wider range of people, particularly in places where people need to be tested quickly, such as airports, or have limited access to laboratory resources, such as schools.”
The CLINITEST Rapid COVID-19 Antigen Test offers an easy solution for health status. It quickly benefits from driving through the nasal and nasopharynx. The samples taken are placed in a container containing special liquid to be targeted. This liquid is then spread on a test cassette and a positive or negative result is clearly produced within 15 minutes. In addition to the CLINITEST Rapid-19 Antigen Test, Siemens Healthineers offers a diagnostic portfolio to aid in the prognosis, treatment and follow-up of COVID-19s. This new test is now one of the 15 critical tests of Siemens Healthineers' 19 selections to be made for users of the future to purchase education and a good evaluation point. Its broad and diversified portfolio for children includes antibody and SARS-2 engineering as well as hematology, heart, disease-CoV disease panel tests. You'll cover blood gas and approaches from Siemens Healthineers with results that help clinicians in warming patients with COVID-19.
As societies try to overcome the COVID-19 epidemic, preventing the spread of the virus with a quick and easy test that is accessible to everyone emerges as a critical need for public health. To address this need, Siemens Healthineers offers an easy-to-use antigen test for the detection of the SARS-CoV-2 virus that causes COVID-19. The bedside cassette test CLINITEST Rapid COVID-19 Antigen Test1 does not require laboratory tools or specialists for administration and provides results within 15 minutes. Developed and tested by a Siemens Healthineers solution partner, this CE-certified test shows 96.72% sensitivity and 99.2% specificity, according to a clinical study on 317 subjects. This research was carried out with the participation of operators of different competencies at six different locations, including a hospital, a health center, a university campus and an oncology unit. Siemens Healthineers aims to meet such testing needs as the pandemic continues to spread. However, the test is awaiting completion of FDA review for Emergency Use Authorization. Head of Bedside Diagnostics at Siemens Healthineers PhD. Christoph Pedain states: “There is a great need for reliable tests that can quickly identify individuals with the virus and help minimize the spread of COVID-19, especially in areas where people gather and traffic is high. As quality is at the forefront of test reliability criteria for decision makers, it was extremely important that the clinical investigation for this test be able to evaluate the variable clinical conditions that can be expected when performing a rapid antigen test. “This rapid antigen test makes SARS-CoV-2 testing accessible to a wider range of people, particularly in places where people need to be tested quickly, such as airports, or have limited access to laboratory resources, such as schools.”
The CLINITEST Rapid COVID-19 Antigen Test offers an easy solution for health status. It quickly benefits from driving through the nasal and nasopharynx. The samples taken are placed in a container containing special liquid to be targeted. This liquid is then spread on a test cassette and a positive or negative result is clearly produced within 15 minutes. In addition to the CLINITEST Rapid-19 Antigen Test, Siemens Healthineers offers a diagnostic portfolio to aid in the prognosis, treatment and follow-up of COVID-19s. This new test is now one of the 15 critical tests of Siemens Healthineers' 19 selections to be made for users of the future to purchase education and a good evaluation point. Its broad and diversified portfolio for children includes antibody and SARS-2 engineering as well as hematology, heart, disease-CoV disease panel tests. You'll cover blood gas and approaches from Siemens Healthineers with results that help clinicians in warming patients with COVID-19.
As societies try to overcome the COVID-19 epidemic, preventing the spread of the virus with a quick and easy test that is accessible to everyone emerges as a critical need for public health. To address this need, Siemens Healthineers offers an easy-to-use antigen test for the detection of the SARS-CoV-2 virus that causes COVID-19. The bedside cassette test CLINITEST Rapid COVID-19 Antigen Test1 does not require laboratory tools or specialists for administration and provides results within 15 minutes. Developed and tested by a Siemens Healthineers solution partner, this CE-certified test shows 96.72% sensitivity and 99.2% specificity, according to a clinical study on 317 subjects. This research was carried out with the participation of operators of different competencies at six different locations, including a hospital, a health center, a university campus and an oncology unit. Siemens Healthineers aims to meet such testing needs as the pandemic continues to spread. However, the test is awaiting completion of FDA review for Emergency Use Authorization. Head of Bedside Diagnostics at Siemens Healthineers PhD. Christoph Pedain states: “There is a great need for reliable tests that can quickly identify individuals with the virus and help minimize the spread of COVID-19, especially in areas where people gather and traffic is high. As quality is at the forefront of test reliability criteria for decision makers, it was extremely important that the clinical investigation for this test be able to evaluate the variable clinical conditions that can be expected when performing a rapid antigen test. “This rapid antigen test makes SARS-CoV-2 testing accessible to a wider range of people, particularly in places where people need to be tested quickly, such as airports, or have limited access to laboratory resources, such as schools.”
The CLINITEST Rapid COVID-19 Antigen Test offers an easy solution for health status. It quickly benefits from driving through the nasal and nasopharynx. The samples taken are placed in a container containing special liquid to be targeted. This liquid is then spread on a test cassette and a positive or negative result is clearly produced within 15 minutes. In addition to the CLINITEST Rapid-19 Antigen Test, Siemens Healthineers offers a diagnostic portfolio to aid in the prognosis, treatment and follow-up of COVID-19s. This new test is now one of the 15 critical tests of Siemens Healthineers' 19 selections to be made for users of the future to purchase education and a good evaluation point. Its broad and diversified portfolio for children includes antibody and SARS-2 engineering as well as hematology, heart, disease-CoV disease panel tests. You'll cover blood gas and approaches from Siemens Healthineers with results that help clinicians in warming patients with COVID-19.